Seven Eight Capital’s Arcellx ACLX Stock Holding History

Seven Eight Capital’s Portfolio ACLX Stock Details ACLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-17,351	Closed	-$1.21M	–	671
2024 Q1	$1.21M	Buy	+17,351	New	+$1.1M	0.13%	255

Other funds holding ACLX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Seven Eight Capital's ACLX Position: Q2 2024 in Review

Seven Eight Capital sold out of Arcellx (ACLX) in Q2 2024, closing a stake of 17,351 shares — an estimated $1.21M sold.

Seven Eight Capital first reported a position in ACLX in Q1 2024 and held it in 1 quarter. The position peaked at $1.21M in Q1 2024. 167 funds tracked by Wall St. Rank hold ACLX as of Q2 2024.

Seven Eight Capital reported no remaining Arcellx position as of Q2 2024 after selling out during the quarter.
Seven Eight Capital sold 17,351 Arcellx shares in Q2 2024, an estimated $1.21M.
Seven Eight Capital first reported a position in Arcellx in Q1 2024 and held it in 1 quarter.
Seven Eight Capital's Arcellx position peaked at $1.21M in Q1 2024.
167 funds tracked by Wall St. Rank held Arcellx as of Q2 2024.

Based on Seven Eight Capital's 13F filing for Q2 2024, filed 12 Aug 2024.